Quality of Life Variations Among Adolescent Females Following Virtual Reality Games Approach

December 4, 2024 updated by: Mina Atef Georgui Elias
to compare the effects of virtual reality games, aerobic exercise, and dietary modifications on Quality of Life among adolescent females.

Study Overview

Detailed Description

The study will assess whether virtual reality games, aerobic exercise, and dietary modifications lead to significant differences in Quality of Life scores, and perceived exertion as measured by the Borg scale. Additionally, the study will evaluate whether these interventions produce varying impacts on psychological factors such as depression, anxiety, and stress, and on physical measurements like waist circumference (WC) and body fat composition.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • El-Mahaba Specialized Charity Polyclinics
      • Cairo, Egypt
        • Badr University in Cairo faculty of physical therapy
      • Zagazig, Egypt
        • Life clinic (Private Clinic) - Minya Al Qamh - Sharqia Governorate

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Obese adolescent girls
  • Class I Obesity (Body Mass Index from 30 to 34.99 kg/m2)
  • Have regular menstruation
  • Clinically and medically stable
  • no impairment of sensation or other neurological or psychological problems

Exclusion Criteria:

  • Visual and/or auditory defects
  • Normal weight girls (Body Mass Index from 18 to 24.99 kg/m2) or below average weight (BMI less than 18 kg/m2) or Class II & III Obesity (BMI above 35 kg/m2)
  • Girls with significant tightness and/or fixed deformity of lower limbs
  • Participants with neurological disorders that affect balance or mentality (e.g. epilepsy).
  • Girls with advanced radiographic changes include: Bone destruction, Bony ankylosis, Knee joint subluxation, and Epiphysial fracture)
  • Congenital or acquired lower limb deformities in the lower limbs.
  • Cardiopulmonary dysfunction.
  • Girls under insulin therapy, uncontrolled bronchial asthma, anemia, and Pathological causes of obesity (endocrinal, genetic syndromes...etc.).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Exercise
The group included 50 girls who received diet advice, aerobic and virtual reality exercises 3 times per week for 8 weeks. they received diet advice and aerobic exercises in form of cycle ergometer training (Each girl started session with a 5 min of warm-up. The exercise phase is performed at 65-75% of age-predicted peak heart rate using an orbitrack device for 20 minutes). Then This was followed by the main part, which consisted of 25 min of exercise when girl immersed in the game and did physical activities for the upper and lower extremities according to the game's requirements, and finally a 5 min cool-down part to lower the heart rate and end the session with static flexibility routines, the total session that would be applied about 50 min (including 30 mins of Virtual reality exercises)
aerobic exercises in form of cycle ergometer training (Each girl started session with a 5 min of warm-up. The exercise phase is performed at 65-75% of age-predicted peak heart rate using an orbitrack device for 20 minutes). Finally, a 5 min cool-down period is permitted, the total session that would be applied about 30 min.
Adolescent girls participated in the study receive diet advices based on a balanced low calorie diet (1500 Kcal)
Virtual reality game exercise involves 25 min of exercise where adolescent girl immersed in the game and did physical activities for the upper and lower extremities according to the game's requirements, and finally a 5 min cool-down part to lower the heart rate and end the session with static flexibility routines, the total session that would be applied about 30 min of Virtual reality exercises.
Active Comparator: Control group (aerobic exercise)
This group serves as the control group, it included 50 girls who received diet advice and aerobic exercises in form of cycle ergometer training for 3 times per week for 8 weeks. Each girl started session with a 5 min of warm-up. The exercise phase is performed at 65-75% of age-predicted peak heart rate using an orbitrack device for 20 minutes. Finally, a 5 min cool-down period is permitted, the total session that would be applied about 30 min.
aerobic exercises in form of cycle ergometer training (Each girl started session with a 5 min of warm-up. The exercise phase is performed at 65-75% of age-predicted peak heart rate using an orbitrack device for 20 minutes). Finally, a 5 min cool-down period is permitted, the total session that would be applied about 30 min.
Adolescent girls participated in the study receive diet advices based on a balanced low calorie diet (1500 Kcal)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass index
Time Frame: From enrollment to the end of treatment at 8 weeks
It is the weight (in kilograms) divided by the height (in meter squares)
From enrollment to the end of treatment at 8 weeks
Fat Mass
Time Frame: From enrollment to the end of treatment at 8 weeks
Body fat mass percentage measured by body composition analysis device
From enrollment to the end of treatment at 8 weeks
Body Water Content
Time Frame: From enrollment to the end of treatment at 8 weeks
Total body water content percentage measured by body composition analysis device.
From enrollment to the end of treatment at 8 weeks
Muscle mass
Time Frame: From enrollment to the end of treatment at 8 weeks
Body muscle mass percentage measured by body composition analysis device.
From enrollment to the end of treatment at 8 weeks
Waist Circumference
Time Frame: From enrollment to the end of treatment at 8 weeks
Waist circumference measured in centimeters, where the patient would be in standing position while investigator applied the tape round the abdomen at its narrowest point between the lower rib margin and top of iliac crest at the end of quiet expiration.
From enrollment to the end of treatment at 8 weeks
Waist hip ratio
Time Frame: From enrollment to the end of treatment at 8 weeks
It is the ratio between the waist circumference and the hip circumference. Where the waist circumference should be measured at the midpoint between the lower margin of the last palpable ribs and the top of the iliac crest, using a tape measurement. While, the hip circumference should be measured around the widest portion of the buttocks, with the tape parallel to the floor.
From enrollment to the end of treatment at 8 weeks
Borg Scale (rate of perceived exertion)
Time Frame: From enrollment to the end of treatment at 8 weeks
This is the modified Borg scale (rating from 0 to 10) where 0 means "no exertion at all" and 20 means "maximal exertion." When a measurement is taken, a number is chosen from the scale by the participant that best describes their perceived level of exertion during physical activity (Six-Minute walk test)
From enrollment to the end of treatment at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Menstrual pain by Visual Analogue Scale (VAS)
Time Frame: From enrollment to the end of treatment at 8 weeks
The VAS is a 10-point scale comprising a number from 0 through 10; 0 indicates no pain, and 10 indicates the worst imaginable pain. Adolescent girls participating in the study were instructed to choose a single number from the scale that best indicates their level of menstrual pain
From enrollment to the end of treatment at 8 weeks
Pediatric Quality of Life Inventory (PedsQL)
Time Frame: From enrollment to the end of treatment at 8 weeks

It is a 23-item generic health status instrument that assesses five domains of health (physical functioning, emotional functioning, psychosocial functioning, social functioning, and school functioning) in adolescents.

The PedsQL 4.0 has been proposed as a valid and reliable generic pediatric HRQOL measurement that can be used for self-reports in age groups ranging from 2 to 18 years and can also be used in clinical practice, clinical trials, and research, as well as school health settings, and community populations.

It is a questionnaire for the child about child's physical, emotional, social, and school functioning in the past one month. On the PedsQL Generic Core Scales, for ease of interpretability, items are reversed scored and linearly transformed to a 0-100 scale, so that higher scores indicate better HRQOL (Health-Related Quality of Life).

From enrollment to the end of treatment at 8 weeks
Depression Score
Time Frame: From enrollment to the end of treatment at 8 weeks

Through the DAAS-21 scale (Depression, Anxiety and Stress scoring and degree)

It consists of 21 questions, seven questions for depression, seven for anxiety and seven for stress assessment. The DASS is a quantitative measure of distress along the 3 axes of depression, anxiety and stress.

From enrollment to the end of treatment at 8 weeks
Anxiety Score
Time Frame: From enrollment to the end of treatment at 8 weeks

Through the DAAS-21 scale (Depression, Anxiety and Stress scoring and degree)

It consists of 21 questions, seven questions for depression, seven for anxiety and seven for stress assessment. The DASS is a quantitative measure of distress along the 3 axes of depression, anxiety and stress.

From enrollment to the end of treatment at 8 weeks
Stress Score
Time Frame: From enrollment to the end of treatment at 8 weeks

Through the DAAS-21 scale (Depression, Anxiety and Stress scoring and degree)

It consists of 21 questions, seven questions for depression, seven for anxiety and seven for stress assessment. The DASS is a quantitative measure of distress along the 3 axes of depression, anxiety and stress.

From enrollment to the end of treatment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Doaa Saeed, PhD, Lecturer Dept. of PT for Women's Health Faculty of Physical Therapy Badr University in Cairo, Egypt
  • Principal Investigator: Radwa S Abdulrahman, PhD, Ass. Prof. Dept. of PT for Pediatric, Faculty of Physical Therapy, Badr University in Cairo, Egypt.
  • Study Chair: Hayam M Mahmoud, PhD, Professor Dept. of PT for Neurology & Neurosurgery, Faculty of Physical Therapy, Cairo Univ. Egypt.
  • Study Chair: Wael OA Abd El-Khalek, PhD, Lecturer, Dept. of Basic Sciences, Faculty of Physical Therapy, Badr University in Cairo, Egypt.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

September 30, 2024

Study Completion (Actual)

November 1, 2024

Study Registration Dates

First Submitted

September 17, 2024

First Submitted That Met QC Criteria

September 17, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

December 5, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Aerobic exercise

Subscribe